Metastatic Poorly Differentiated Thyroid Cancer Completed Phase 2 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0040043 (Metastatic Poorly Differentiated Thyroid Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00654238Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid CancerTreatment